Over the course of six months, study participants will get monthly at-home kits for viral and antibody testing. They’ll also complete routine surveys and can seek additional testing if they develop symptoms, officials said.
Ongoing study results could reveal warning signs about how COVID-19 cases are changing in the Boston area. It will also help clinicians learn more about whether contracting the virus protects someone from future reinfection, according to the statement.
TestBoston will be led by Dr. Ann Woolley and Dr. Lisa Cosimi, infectious disease physicians at Brigham and Women’s, and Dr. Deborah Hung, a codirector of the Infectious Disease and Microbiome Program of the Broad Institute and an infectious disease and critical care physician at the Brigham.
“With ongoing limits on testing availability, we still face serious challenges to our understanding of how many people in Massachusetts have been infected and to our ability to detect new outbreaks,